The PROGRxN-BCa study, led by Jethro C.C. Kwong, showcases a major advancement in predicting disease progression in non–muscle-invasive bladder cancer through artificial intelligence (AI).
Jethro C.C. Kwong
Jethro C.C. Kwong is a urology resident from the University of Toronto.
Articles by Jethro C.C. Kwong
Jethro C.C. Kwong discusses a novel artificial intelligence-based model, PROGRxN-BCa.